Dermata Therapeutics Inc. (DRMA)
NASDAQ: DRMA
· Real-Time Price · USD
5.91
-0.54 (-8.30%)
At close: Aug 14, 2025, 3:44 PM
5.81
-1.61%
Pre-market: Aug 15, 2025, 07:00 AM EDT
-8.30% (1D)
| Bid | 5.75 |
| Market Cap | 3.77M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -11.46M |
| EPS (ttm) | -14.2 |
| PE Ratio (ttm) | -0.42 |
| Forward PE | -0.59 |
| Analyst | Buy |
| Ask | 5.81 |
| Volume | 50,550 |
| Avg. Volume (20D) | 15,537 |
| Open | 6.36 |
| Previous Close | 6.45 |
| Day's Range | 5.91 - 6.54 |
| 52-Week Range | 5.74 - 24.90 |
| Beta | 0.56 |
About DRMA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DRMA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DRMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+5.19%
Dermata shares are trading higher after the compan...
Unlock content with
Pro Subscription
8 months ago
+19.01%
Dermata Therapeutics shares are trading higher after the company received a notice of allowance for a U.S. patent titled "COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN CONDITIONS (INCLUDING ACNE)"
